Phaarmasia Ltd.
BSE: 523620 | Sector: Health care |
NSE: N.A. | ISIN Code: INE486I01016 |
BSE 00:00 | 20 Mar | 26.00 |
0.60 (2.36%) |
OPEN
26.60 |
HIGH
26.60 |
LOW
24.13 |
NSE 05:30 | 01 Jan | Phaarmasia Ltd |
OPEN | 26.60 |
PREVIOUS CLOSE | 25.40 |
VOLUME | 1424 |
52-Week high | 34.35 |
52-Week low | 20.20 |
P/E | |
Mkt Cap.(Rs cr) | 18 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Phaarmasia Ltd. (PHAARMASIA) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 961.25 | 0.37 | 1071.90 | 789.75 | 230632.71 |
Divi's Lab. | 2798.95 | 0.32 | 4640.95 | 2730.00 | 74298.13 |
Dr Reddy's Labs | 4441.80 | 0.15 | 4645.55 | 3787.55 | 73964.86 |
Cipla | 867.25 | -0.81 | 1185.20 | 853.50 | 70000.08 |
Apollo Hospitals | 4305.45 | -0.99 | 4915.00 | 3365.90 | 61903.76 |
Torrent Pharma. | 1522.10 | -0.55 | 1722.70 | 1242.50 | 51513.95 |
Zydus Lifesci. | 475.85 | -0.21 | 488.10 | 319.40 | 48165.54 |
Max Healthcare | 468.10 | 1.72 | 482.50 | 306.00 | 45448.76 |
Abbott India | 21304.00 | 1.89 | 22481.80 | 15868.70 | 45271.00 |
Alkem Lab | 3108.65 | -0.20 | 3720.00 | 2835.00 | 37163.91 |
Lupin | 646.20 | -1.67 | 798.90 | 583.05 | 29402.10 |
Aurobindo Pharma | 474.25 | -0.33 | 730.00 | 397.30 | 27786.31 |
Biocon | 201.80 | 0.00 | 387.80 | 199.00 | 24228.11 |
Syngene Intl. | 575.75 | -0.36 | 682.25 | 511.50 | 23112.33 |
Glaxosmi. Pharma | 1281.75 | -0.50 | 1734.90 | 1230.70 | 21714.13 |
Ipca Labs. | 780.85 | -0.17 | 1089.00 | 768.00 | 19810.17 |
Fortis Health. | 260.45 | -0.86 | 324.80 | 219.80 | 19662.93 |
Gland Pharma | 1163.80 | -2.07 | 3556.10 | 1130.40 | 19167.79 |
Laurus Labs | 302.40 | -0.21 | 626.00 | 298.50 | 16288.78 |
Narayana Hrudaya | 795.30 | -1.54 | 816.20 | 589.90 | 16252.75 |
Quick Links for Phaarmasia:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices